EUVIMEDEUVIMED entdecken
Crossref

Bioconversion of lovastatin to simvastatin by Streptomyces carpaticus toward the inhibition of HMG‐CoA activity

Janani Balraj, Thandeeswaran Murugesan, Anand Raj Dhanapal, Vidhya Kalieswaran, Karunyadevi Jairaman, Govindaraju Archunan, Angayarkanni Jayaraman iD

Biotechnology and Applied Biochemistry · 2023

DOI: 10.1002/bab.2429 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biotechnology and Applied Biochemistry, 2023. Verfasst von Janani Balraj und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbial Biotechnology, Bharathiar University, Coimbatore, Tamil Nadu, India. Hauptthemen laut MEDLINE: Lovastatin, Hydroxymethylglutaryl-CoA Reductase Inhibitors. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 61 Literaturangaben. Gefördert von: Department of Science and Technology, DST FIST.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The aim of this study was the modification of lovastatin by microbes to improve its potential. Actinobacteria exhibit staggering diversity in terms of their biosynthetic capability for specialized metabolites which has been traced back to the presence of specialized gene clusters. The objective of the study is to exploit the potential of Actinobacteria strain(s), which can biotransform lovastatin to simvastatin, which might be a more potent therapeutic agent than lovastatin. We have screened 40 Actinobacteria strains and assessed their biotransformation potential primarily through thin layer chromatography (TLC) analysis, followed by high performance thin layer chromatography and high performance liquid chromatography analysis. One strain C7 (CTL S12) has been identified as a potential Actinobacteria that favored the simvastatin biotransformation. The morphological and biochemical analysis together with 16S rRNA sequencing coupled with phylogenetic analysis confirmed the ideal strain (C7) as Streptomyces carpaticus . Successively, the purified simvastatin from S. carpaticus was characterized by liquid chromatography–mass spectrometry (LC–MS), infrared spectrometry, nuclear magnetic resonance, and HMG‐CoA assay. In the LC–MS analysis, a peak at 419.24 m/z confirmed the elemental composition of simvastatin (C 25 H 39 O 5 ). In HMG‐CoA assay, the IC50 of simvastatin was 50 μg/ml, and the inhibitory potential was 1.36 times higher compared to that of lovastatin. Thus, the biotransformation of simvastatin from lovastatin by S. carpaticus is reported for the first time.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LovastatinHydroxymethylglutaryl-CoA Reductase InhibitorsPhylogenySimvastatinRNA, Ribosomal, 16SAcyl Coenzyme AStreptomyces

Stichwörter der Autor:innen

HMG-CoAStreptomyces carpaticusbiotransformationenzymelovastatinsimvastatin

Substanzen

LovastatinHydroxymethylglutaryl-CoA Reductase InhibitorsSimvastatinRNA, Ribosomal, 16S3-hydroxy-3-methylglutaryl-coenzyme AAcyl Coenzyme A

Autor:innen und Institutionen

  • Department of Microbial Biotechnology, Bharathiar University, Coimbatore, Tamil Nadu, India.
  • Bharathiar Cancer Theranostics Research Centre, RUSA2.0, 641046, Bharathiar University, Coimbatore, Tamil Nadu, India.
  • Centre for Plant Tissue Culture and Central Instrumentation Laboratory, Karpagam Academy of Higher Education, Coimbatore, Tamil Nadu, India.
  • Department of Biotechnology, Karpagam Academy of Higher Education, Coimbatore, Tamil Nadu, India.
  • Dean-Research, Marudupandiyar college, 613403, Thanjavur, Tamil Nadu, India.

ORCID-Profile: Angayarkanni Jayaraman

Förderung

  • Department of Science and Technology
  • DST FIST

Zitieren

APA

Balraj, J., Murugesan, T., Dhanapal, A. R., Kalieswaran, V., Jairaman, K., Archunan, G., & Jayaraman, A. (2023). Bioconversion of lovastatin to simvastatin by Streptomyces carpaticus toward the inhibition of HMG‐CoA activity. Biotechnology and Applied Biochemistry. https://doi.org/10.1002/bab.2429

Vancouver

Balraj J, Murugesan T, Dhanapal AR, Kalieswaran V, Jairaman K, Archunan G, et al. Bioconversion of lovastatin to simvastatin by Streptomyces carpaticus toward the inhibition of HMG‐CoA activity. Biotechnology and Applied Biochemistry. 2023. doi:10.1002/bab.2429

BibTeX
@article{Balraj2023,
  author = {Balraj, Janani and Murugesan, Thandeeswaran and Dhanapal, Anand Raj and Kalieswaran, Vidhya and Jairaman, Karunyadevi and Archunan, Govindaraju and Jayaraman, Angayarkanni},
  title = {Bioconversion of lovastatin to simvastatin by Streptomyces carpaticus toward the inhibition of HMG‐CoA activity},
  journal = {Biotechnology and Applied Biochemistry},
  year = {2023},
  doi = {10.1002/bab.2429}
}
Kostenlos starten →